Medtronic (MDT)

As the S&P 500 navigates a dynamic market on October 3, 2025, the Healthcare sector has emerged as a steadfast performer, demonstrating remarkable resilience and contributing significantly to the overall market's strength. This stability comes at a crucial time, as the technology sector experiences a notable pullback, leading investors

Merit Medical Systems (NASDAQ: MMSI) has announced a significant milestone for its SCOUT Radar Localization technology, which has now been utilized in over 750,000 patient procedures worldwide. This achievement, coinciding with Breast Cancer Awareness Month, underscores the widespread adoption and critical impact of the wire-free, non-radioactive localization device in

The financial markets are buzzing with the significant upward trajectory of several big tech and tech-adjacent companies, with prominent players like Palo Alto Networks, Intel, Travelers, and Medtronic reportedly reaching new valuation highs. This surge, observed around October 2025, signals a robust investor confidence in the technology sector's resilience and

On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's resilience. Despite prevailing anxieties, including a looming U.S. government shutdown and a disappointing jobs report, healthcare equities

The growth of surgical robots is huge, and this company is looking to get in on the action while it also works to boost its profit margin.

The stock can bring stability amid volatile economic conditions.

As of October 1, 2025, Artificial Intelligence (AI) has transcended its nascent stages, becoming an indispensable force in high-value professional tasks across medicine, law, and consulting. This transformative shift is redefining traditional workflows, demanding a radical re-evaluation of skill sets, and igniting critical discussions around ethics, regulation, and the very

As of late September 2025, the specter of a US government shutdown casts a long shadow over financial markets, prompting an immediate atmosphere of caution and uncertainty. With the fiscal year-end deadline of September 30 rapidly approaching, stock futures, the S&P 500, Dow, and Nasdaq are all feeling the

The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—including PPE, consumables, and medical devices—to assess reliance on foreign suppliers for critical health products.

Surgical technology is advancing quickly, and robots are the future, which is why you'll want to look at this high-yield surgical robot maker.

The pharmaceutical landscape is currently a tale of two giants employing vastly different, yet highly successful, growth strategies. Eli Lilly and Company (NYSE: LLY) has placed an extraordinary bet on the burgeoning market for weight-loss and diabetes drugs, driven by its groundbreaking GLP-1 agonists. In stark contrast, Johnson & Johnson (NYSE:

Johnson & Johnson (NYSE: JNJ), the global healthcare titan, has once again underscored its formidable market position and unwavering commitment to shareholder value, reporting a robust second quarter for 2025. The company's performance was marked by significant growth across its Innovative Medicine and MedTech segments, showcasing the strategic success of its

Medtronic is one of the largest medical device makers in the world, and it is focused on getting more profitable.

Medtronic's Altaviva wins FDA approval as a minimally invasive implant for urge urinary incontinence, offering long-lasting and low-maintenance therapy.

In a financial landscape increasingly dominated by the exhilarating, often volatile, narrative of artificial intelligence, Intuitive Surgical (NASDAQ: ISRG) stands as a testament to steady, fundamental innovation. As the market's gaze fixates on every whisper of AI advancement, the pioneer of robotic-assisted surgery continues its work, quietly refining its formidable

Sunnyvale, CA – September 17, 2025 – Intuitive Surgical (NASDAQ: ISRG), the pioneer and global leader in robotic-assisted surgery, has once again demonstrated its formidable market position with a robust second-quarter 2025 earnings report. The company announced an impressive adjusted Earnings Per Share (EPS) of $2.19, significantly surpassing analyst expectations, coupled

The storied medical device specialist always seems to post encouraging growth.

Find out how the company's da Vinci surgical robots could remain the preferred option for decades.

Medtronic (MDT) offers a strong 3.01% dividend yield, a history of reliable payouts, and solid profitability, making it a top candidate for sustainable income investors.

An unbeatable advantage makes this stock a popular one among billionaire investors.

They have increased their payouts for a combined 111 straight years.

The healthcare industry is currently experiencing a transformative "golden age," a period marked by an unprecedented surge in scientific breakthroughs and technological advancements. This era is fundamentally altering the landscape of medical treatment and diagnostics, promising a future of more personalized, precise, and preventive medicine. At the forefront of this